Bowen Hanes & CO Inc Eli Lilly & CO Transaction History

Bowen Hanes & CO Inc

$3.8 Billion
Q3 2024

A detailed history of Bowen Hanes & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 125,314 shares of LLY stock, worth $99.7 Million. This represents 2.92% of its overall portfolio holdings.

Number of Shares

125,314

Previous 125,817 0.4%

Holding current value

$99.7 Million

Previous $114 Million 2.54%

% of portfolio

2.92%

Previous 3.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $388,386 - $482,890	-503 Reduced 0.4%	125,314 $111 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $7.74 Million - $9.71 Million	-10,683 Reduced 7.83%	125,817 $114 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $2.64 Million - $3.53 Million	-4,454 Reduced 3.16%	136,500 $106 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $6.15 Million - $7.24 Million	-11,701 Reduced 7.66%	140,954 $82.2 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $3.23 Million - $4.45 Million	-7,420 Reduced 4.64%	152,655 $82 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.28 Million - $1.71 Million	-3,640 Reduced 2.22%	160,075 $75.1 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $1.04 Million - $1.22 Million	-3,339 Reduced 2.0%	163,715 $56.2 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $1.16 Million - $1.35 Million	-3,605 Reduced 2.11%	167,054 $61.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $462,508 - $527,077	1,560 Added 0.92%	170,659 $55.2 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $207,932 - $244,143	-746 Reduced 0.44%	169,099 $54.8 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $2.61 Million - $3.24 Million	11,120 Added 7.01%	169,845 $48.6 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $35.7 Million - $44.3 Million	158,725 New	158,725 $43.8 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $1.67 Million - $1.97 Million	-15,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $1.59 Million - $1.78 Million	15,000 New	15,000 $1.74 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.

Account

Bowen Hanes & CO Inc Eli Lilly & CO Transaction History